Renovaro Biosciences Ownership | Who Owns Renovaro Biosciences?

Renovaro Biosciences Ownership Summary

Renovaro Biosciences is owned by 8.89% institutional investors, 36.71% insiders, and 54.40% retail investors. Vanguard group is the largest institutional shareholder, holding 3.65% of RENB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.06% of its assets in Renovaro Biosciences shares.

RENB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Renovaro Biosciences	8.89%	36.71%	54.40%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	5.72M	3.65%	$4.78M
Blackrock funding, inc. /de	2.70M	1.66%	$779.49K
Geode capital management	2.33M	1.49%	$1.95M
State street	2.06M	1.32%	$1.73M
Ubs group	763.70K	0.49%	$638.46K
Goldman sachs group	364.48K	0.23%	$304.52K
Jpmorgan chase	353.83K	0.23%	$295.63K
Marshall wace, llp	309.35K	0.19%	$89.71K
Bank of new york mellon	223.91K	0.14%	$187.08K
Qube research	228.88K	0.14%	$66.13K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Point72 asia (singapore) pte.	55.45K	0.00%	$16.02K
Two sigma securities	12.99K	0.00%	$3.75K
Geode capital management	2.33M	0.00%	$1.95M
Tower research capital llc (trc)	12.22K	0.00%	$10.22K
Y-intercept (hong kong)	14.52K	0.00%	$4.19K
Marshall wace, llp	309.35K	0.00%	$89.71K
Citigroup	187.52K	0.00%	$156.67K
State street	2.06M	0.00%	$1.73M
Commonwealth equity services	101.57K	0.00%	$85.00K
Ubs group	763.70K	0.00%	$638.46K

Top Buyers

Holder	Shares	% Assets	Change
Geode capital management	2.33M	0.00%	760.34K
State street	2.06M	0.00%	741.03K
Ubs group	763.70K	0.00%	717.25K
Marshall wace, llp	309.35K	0.00%	309.35K
Goldman sachs group	364.48K	-	271.59K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	2.70M	-	-4.66M
Charles schwab investment management	-	-	-362.13K
Cantor fitzgerald, l. p.	-	-	-300.00K
Rhumbline advisers	-	-	-123.01K
Barclays	-	-	-119.83K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	309.35K	0.00%	309.35K	$89.71K
Qube research	228.88K	0.00%	228.88K	$66.13K
Deutsche bank ag\	127.44K	-	127.44K	$107.05K
Point72 asia (singapore) pte.	55.45K	0.00%	55.45K	$16.02K
Y-intercept (hong kong)	14.52K	0.00%	14.52K	$4.19K

Sold Out

Holder	Change
Pnc financial services group	-41.00
True wealth design	-56.00
Sterling capital management	-749.00
Coldstream capital management	-1.56K
Russell investments group	-3.20K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	43	-32.81%	14,426,097	-34.47%	8	4.83%	22	-24.14%	16	-15.79%
Mar 31, 2025	64	6.67%	22,014,123	-0.53%	13	6.79%	29	-35.56%	19	171.43%
Dec 31, 2024	25	-51.92%	16,578,249	12.30%	10	11.91%	16	-48.39%	3	-57.14%
Sep 30, 2024	52	36.84%	14,762,408	4.27%	9	4.36%	31	10.71%	7	-
Jun 30, 2024	38	-11.63%	14,157,443	95.26%	14	32.32%	28	-3.45%	7	-12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	3.34M	2.06%	-1.00
Vanguard Total Stock Mkt Idx Inv	3.27M	1.42%	-71.48K
State St Russell Sm/Mid Cp® Indx NL Cl C	940.16K	0.58%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	940.16K	0.55%	-
Fidelity Small Cap Index	1.13M	0.49%	-
Vanguard Institutional Extnd Mkt Idx Tr	964.99K	0.42%	-439.72K
iShares Russell 2000 ETF	674.10K	0.39%	-11.34K
Vanguard Russell 2000 ETF	573.04K	0.33%	5.09K
Fidelity Extended Market Index	486.47K	0.21%	-1.27K
iShares Russell 2000 Value ETF	351.18K	0.20%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 29, 2024	William Anderson Wittekind	-	Sell	$1.45K
Jul 17, 2024	William Anderson Wittekind	-	Sell	$23.89K
Jul 15, 2024	William Anderson Wittekind	-	Sell	$30.96K
Jul 10, 2024	William Anderson Wittekind	-	Sell	$113.25K
Jul 11, 2024	William Anderson Wittekind	-	Sell	$22.49K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	10
2024 Q2	-	4
2024 Q1	-	-

RENB Ownership FAQ

Who Owns Renovaro Biosciences?

Renovaro Biosciences shareholders are primarily institutional investors at 8.89%, followed by 36.71% insiders and 54.40% retail investors. The average institutional ownership in Renovaro Biosciences's industry, Biotech Stocks , is 304.14%, which Renovaro Biosciences falls below.

Who owns the most shares of Renovaro Biosciences?

Renovaro Biosciences’s largest shareholders are Vanguard group (5.72M shares, 3.65%), Blackrock funding, inc. /de (2.7M shares, 1.66%), and Geode capital management (2.33M shares, 1.49%). Together, they hold 6.80% of Renovaro Biosciences’s total shares outstanding.

Does Blackrock own Renovaro Biosciences?

BlackRock is not among the top 10 institutional shareholders of Renovaro Biosciences.

Who is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested?

Point72 asia (singapore) pte is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 55.45K Renovaro Biosciences shares, valued at 16.02K$.

Who is the top mutual fund holder of Renovaro Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Renovaro Biosciences shares, with 2.06% of its total shares outstanding invested in 3.34M Renovaro Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools